Townsend John 4
4 · Unicycive Therapeutics, Inc. · Filed Aug 14, 2024
Insider Transaction Report
Form 4
Townsend John
Chief Financial Officer
Transactions
- Award
Stock Options
2024-08-12+40,256→ 915,565 totalExercise: $0.34Exp: 2034-08-12→ Common Stock (40,256 underlying)
Footnotes (1)
- [F1]10,064 of the stock options vest on August 12, 2025 and 1/36th of the remaining options vest at the end of each successive month thereafter.